Risk factors for chylothorax after esophagectomy
Editorial

Risk factors for chylothorax after esophagectomy

Naoya Yoshida1,2, Hideo Baba2

1Division of Translational Research and Advanced Treatment against Gastrointestinal Cancer, 2Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuoku, Kumamoto 860-8556, Japan

Correspondence to: Hideo Baba, MD, PhD, FACS. Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuoku, Kumamoto 860-8556, Japan. Email: hdobaba@kumamoto-u.ac.jp.

Provenance: This is an invited Editorial commissioned by the Section Editor Shuangjiang Li (Department of Thoracic Surgery and West China Medical Center, West China Hospital, Sichuan University, Chengdu, China).

Comment on: Ohkura Y, Ueno M, Shindoh J, et al. Risk Factors for Postoperative Chylothorax After Radical Subtotal Esophagectomy. Ann Surg Oncol 2018;25:2739-46.


Submitted Jan 16, 2019. Accepted for publication Feb 13, 2019.

doi: 10.21037/jtd.2019.02.28


Chylothorax commonly occurs after esophagectomy for esophageal cancer and sometimes becomes refractory. When it cannot be cured by conservative treatments, surgery is usually considered (1). It can be associated with significant postoperative mortality, long hospital stay, and high economic burden (2,3). Thus, preventing postoperative chylothorax is one of the important clinical issues during esophagectomy.

At this time, only a few studies of the risk factors for chylothorax after esophagectomy have been conducted (2,4). Shah et al. suggested that certain histological types (squamous cell carcinoma) may be at increased risk for chylothorax. Miao et al. documented that a body mass index <25 kg/m2 was a significant risk. However, Shah et al.’s study included several types of surgery that could affect the incidence of postoperative chylothorax. Miao et al. performed open Ivor Lewis esophagectomy, which is not a standard surgery for esophageal carcinoma in Japan. Thus, in the current study, Ohkura et al. investigated the risk factors for post-esophagectomy chylothorax using comparatively homogenous patients regarding surgery: subtotal esophagectomy with two- or three-field lymphadenectomy, which is the standard surgery in Japan.

This study is considerably important because the investigation of risk factors for chylothorax after subtotal esophagectomy has never been conducted. In this study, the authors documented that preoperative chemoradiotherapy (CRT) and high intraoperative fluid balance were significant risk factors for postoperative chylothorax. Moreover, resection of the thoracic duct (TD) might be a risk.

The reasons for the association between preoperative CRT and postoperative chylothorax that the authors claimed are reasonable and acceptable. Preoperative CRT can induce damage to the lymphatic system and edema in an irradiated field (5). In addition, fibrotic changes after CRT complicates distinguishing the dissection plane in a surgical field and may cause frequent lymphorrhea by inducing microinjuries of the TD and lymphatic network surrounding the TD. In addition, preoperative CRT is usually performed in patients with more advanced esophageal cancer. Advanced cancer with lymph node metastasis often requires extensive lymphadenectomy and concurrent TD resection, which can also be a cause of chylothorax.

The association between intraoperative fluid balance and postoperative chylothorax in this report is a novel and interesting result that has never been reported. Importantly, the authors performed both a retrospective study for risk factors seeking and prospective validation study. They finally confirmed that high intraoperative fluid balances ≥6.55 mL/kg/h were correlated with a frequent incidence of postoperative chylothorax. However, the authentic mechanism of frequent chylothorax in patients with high intraoperative fluid balance remains uncertain. The authors suggested that high fluid balance increases the pressure within the lymphatic vessels, and their slight damage during esophagectomy can result in chylothorax. However, it is difficult to verify whether a high intraoperative fluid balance is truly a cause or result of chylothorax. This is because intraoperative lymphorrhea commonly requires more fluid infusion during surgery. In fact, the authors noted that some patients in a prospective validation study did not meet the target value (6.55 mL/kg/h) of fluid infusion unintentionally. We cannot conclude whether high intraoperative fluid infusion in the study caused chylothorax or was unavoidably administered due to large intraoperative lymphorrhea.

It is also difficult to conclude that TD resection may be associated with frequent chylothorax after esophagectomy. Several previous studies have demonstrated that prophylactic TD ligation can prevent chylothorax after esophagectomy (6,7). As the authors mentioned, differences in patients’ backgrounds can affect the incidence of chylothorax. More advanced cancers in the TD resection group may have contributed to the increasing incidence of chylothorax. In addition, TD resection for complete lymphadenectomy surrounding the TD and prophylactic TD ligation for chylothorax may have different values with regard to chylothorax in esophagectomy. Based on the current results, it is difficult to elucidate the reasons for chylothorax after esophagectomy via a retrospective study.

In addition to the limitations mentioned in the discussion, differences in surgical approaches (open vs. video-assisted thoracoscopic surgery) may affect the current results. Because open esophagectomy is generally correlated with higher blood loss and insensible water loss than those of minimally invasive esophagectomy, it would be better to test the cutoff value of intraoperative fluid balance separately.

In conclusion, this study retrospectively elucidated the risk factors for postoperative chylothorax after esophagectomy. Preoperative CRT confers a reasonable risk of postoperative chylothorax. With regard to the influence of intraoperative fluid balance, a definitive conclusion remains unclear despite a discreet prospective validation study. As the authors mentioned, a further multicenter study with a larger cohort is necessary to reconfirm and strengthen the current results.


Acknowledgements

None.


Footnote

Conflicts of Interest: The authors have no conflicts of interest to declare.


References

  1. Ohkura Y, Ueno M, Iizuka T, et al. Effectiveness of etilefrine regimen for chylothorax after esophagectomy with thoracic duct resection. Esophagus 2018;15:33-8. [Crossref] [PubMed]
  2. Shah RD, Luketich JD, Schuchert MJ, et al. Postesophagectomy chylothorax: incidence, risk factors, and outcomes. Ann Thorac Surg 2012;93:897-903. [Crossref] [PubMed]
  3. Ohkura Y, Ueno M, Shindoh J, et al. Risk Factors for Postoperative Chylothorax After Radical Subtotal Esophagectomy. Ann Surg Oncol 2018;25:2739-46. [Crossref] [PubMed]
  4. Miao L, Zhang Y, Hu H, et al. Incidence and management of chylothorax after esophagectomy. Thorac Cancer 2015;6:354-8. [Crossref] [PubMed]
  5. Congdon CC. The destructive effect of radiation on lymphatic tissue. Cancer Res 1966;26:1211-20. [PubMed]
  6. Crucitti P, Mangiameli G, Petitti T, et al. Does prophylactic ligation of the thoracic duct reduce chylothorax rates in patients undergoing oesophagectomy? A systematic review and meta-analysis. Eur J Cardiothorac Surg 2016;50:1019-24. [Crossref] [PubMed]
  7. Lai FC, Chen L, Tu YR, et al. Prevention of chylothorax complicating extensive esophageal resection by mass ligation of thoracic duct: a random control study. Ann Thorac Surg 2011;91:1770-4. [Crossref] [PubMed]
Cite this article as: Yoshida N, Baba H. Risk factors for chylothorax after esophagectomy. J Thorac Dis 2019;11(Suppl 3):S196-S197. doi: 10.21037/jtd.2019.02.28

Download Citation